ITGB7
Basic information
Region (hg38): 12:53191323-53207282
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ITGB7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 30 | 36 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 30 | 4 | 6 |
Variants in ITGB7
This is a list of pathogenic ClinVar variants found in the ITGB7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-53191634-G-C | not specified | Uncertain significance (May 06, 2022) | ||
12-53191865-C-A | not specified | Uncertain significance (Aug 22, 2023) | ||
12-53191891-C-G | not specified | Uncertain significance (Apr 01, 2024) | ||
12-53191897-G-A | not specified | Uncertain significance (Jan 29, 2024) | ||
12-53191909-G-A | not specified | Uncertain significance (May 13, 2024) | ||
12-53191929-G-A | not specified | Uncertain significance (Oct 02, 2023) | ||
12-53191935-C-T | not specified | Uncertain significance (Oct 27, 2022) | ||
12-53191947-A-G | not specified | Uncertain significance (Mar 01, 2023) | ||
12-53192004-G-A | not specified | Uncertain significance (Jun 10, 2024) | ||
12-53192341-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
12-53192459-T-G | not specified | Uncertain significance (Mar 27, 2023) | ||
12-53192471-G-A | Benign (May 21, 2018) | |||
12-53192479-G-C | not specified | Uncertain significance (Nov 18, 2022) | ||
12-53192490-G-A | Benign (Dec 31, 2019) | |||
12-53192701-C-T | not specified | Uncertain significance (Oct 12, 2022) | ||
12-53192735-T-C | Benign (Dec 31, 2019) | |||
12-53192752-C-T | Benign (Mar 29, 2018) | |||
12-53192784-C-T | not specified | Likely benign (Jan 16, 2024) | ||
12-53192893-A-G | not specified | Uncertain significance (Dec 20, 2021) | ||
12-53192902-G-A | not specified | Uncertain significance (Jun 11, 2024) | ||
12-53193163-C-T | not specified | Uncertain significance (Oct 13, 2023) | ||
12-53193226-C-T | not specified | Likely benign (Jan 23, 2023) | ||
12-53193262-G-A | not specified | Uncertain significance (Dec 11, 2023) | ||
12-53193283-C-T | not specified | Uncertain significance (Dec 03, 2021) | ||
12-53193340-C-T | not specified | Uncertain significance (May 31, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ITGB7 | protein_coding | protein_coding | ENST00000267082 | 14 | 15990 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000237 | 1.00 | 125705 | 0 | 43 | 125748 | 0.000171 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.42 | 394 | 482 | 0.818 | 0.0000292 | 5150 |
Missense in Polyphen | 136 | 192.3 | 0.70723 | 2100 | ||
Synonymous | -1.30 | 219 | 196 | 1.12 | 0.0000117 | 1632 |
Loss of Function | 3.25 | 16 | 37.5 | 0.427 | 0.00000185 | 403 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000149 | 0.000149 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000283 | 0.000281 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000985 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Integrin alpha-4/beta-7 (Peyer patches-specific homing receptor LPAM-1) is an adhesion molecule that mediates lymphocyte migration and homing to gut-associated lymphoid tissue (GALT). Integrin alpha-4/beta-7 interacts with the cell surface adhesion molecules MADCAM1 which is normally expressed by the vascular endothelium of the gastrointestinal tract. Interacts also with VCAM1 and fibronectin, an extracellular matrix component. It recognizes one or more domains within the alternatively spliced CS-1 region of fibronectin. Interactions involves the tripeptide L-D-T in MADCAM1, and L-D-V in fibronectin. Binds to HIV-1 gp120, thereby allowing the virus to enter GALT, which is thought to be the major trigger of AIDS disease. Interaction would involve a tripeptide L-D-I in HIV-1 gp120. Integrin alpha-E/beta-7 (HML-1) is a receptor for E-cadherin.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);Cell adhesion molecules (CAMs) - Homo sapiens (human);ECM-receptor interaction - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Dilated cardiomyopathy (DCM) - Homo sapiens (human);Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human);Regulation of actin cytoskeleton - Homo sapiens (human);Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human);Transcriptional misregulation in cancer - Homo sapiens (human);Intestinal immune network for IgA production - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Integrin-mediated Cell Adhesion;Arrhythmogenic Right Ventricular Cardiomyopathy;Focal Adhesion;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;PI3K-Akt Signaling Pathway;Integrin cell surface interactions;Extracellular matrix organization;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System;Integrin;AlphaE beta7 integrin cell surface interactions;a4b7 Integrin signaling;Beta5 beta6 beta7 and beta8 integrin cell surface interactions;E-cadherin signaling in the nascent adherens junction
(Consensus)
Recessive Scores
- pRec
- 0.232
Intolerance Scores
- loftool
- 0.143
- rvis_EVS
- -1.35
- rvis_percentile_EVS
- 4.63
Haploinsufficiency Scores
- pHI
- 0.110
- hipred
- Y
- hipred_score
- 0.595
- ghis
- 0.536
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.934
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Itgb7
- Phenotype
- cellular phenotype; endocrine/exocrine gland phenotype; embryo phenotype; immune system phenotype; skeleton phenotype; digestive/alimentary phenotype; reproductive system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- cell-matrix adhesion involved in ameboidal cell migration;cell adhesion;cell-matrix adhesion;integrin-mediated signaling pathway;cell migration;extracellular matrix organization;cell adhesion mediated by integrin;heterotypic cell-cell adhesion;substrate adhesion-dependent cell spreading;receptor clustering;viral entry into host cell;regulation of immune response;leukocyte tethering or rolling;T cell migration
- Cellular component
- plasma membrane;focal adhesion;integrin complex;cell surface;membrane;integrin alpha4-beta7 complex;receptor complex;extracellular exosome
- Molecular function
- virus receptor activity;integrin binding;protein binding;signaling receptor activity;metal ion binding;cell adhesion molecule binding